Trial
NCT01614067
Delayed Start to Ovarian Stimulation
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, San Francisco
Collaborators
Merck Sharp & Dohme LLC
Condition
Diminished Ovarian Reserve
Intervention
Ganirelix acetate
Why stopped
Slow enrollment resulted in withdraw of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-15